公开(公告)号：US20200163962A1

公开(公告)日：2020-05-28

申请号：US16085246

申请日：2017-03-17

Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.

Inventor： Harshal JAHAGIRDAR ,  Bhushan JADHAV ,  Amol KULKARNI ,  Shirish KULKARNI ,  Rajamannar THENNATI

IPC: A61K31/506 ,  A61K9/48 ,  A61K9/14

Abstract: A method of treating leukaemia comprising orally administering to a patient in need thereof reduced daily doses of nilotinib of 100 mg to 600 mg, wherein the nilotinib is administered in a dosage form having a composition comprising nilotinib butanedisulphonate (2:1) or nilotinib butanedisulphonate (1:1).

公开(公告)号：US20180147238A1

公开(公告)日：2018-05-31

申请号：US15577489

申请日：2016-05-27

Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.

Inventor： Rajamannar THENNATI ,  Shriprakash Dhar DWIVEDI ,  V S N Murty KADIYALA, V ,  Kanaksinh Jesingbhai JADAV ,  Bharat Avcharbhai KAILA ,  Keyur Shashikant THAKER ,  Binaka Rahul DOLE

IPC: A61K33/26 ,  A61P7/06

CPC classification number: A61K33/26 ,  A61K9/0019 ,  A61K9/08 ,  A61K31/7135 ,  A61P7/06 ,  C07H1/00 ,  C07H23/00

Abstract: The present invention relates to composition of iron sucrose and process for its preparation. The present invention also related to a process for the preparation of iron sucrose suitable for the iron sucrose composition.

公开(公告)号：US20140031550A1

公开(公告)日：2014-01-30

申请号：US14013873

申请日：2013-08-29

Applicant: Sun Pharmaceutical Industries Ltd.

Inventor： Nileshkumar Sureshbhai PATEL ,  Srinivasu KILARU ,  Rajamannar THENNATI

IPC: C07D489/12

CPC classification number: C07D489/12 ,  C07D489/10

Abstract: The present invention relates to an improved process for preparing morphinane analogues of formula 1 wherein the substituents R1, R2, R2a, R3, R4, R5 and Y have the meanings as defined in the specifications.

Abstract translation: 本发明涉及一种制备式1的吗啡烷类似物的改进方法，其中取代基R 1，R 2，R 2a，R 3，R 4，R 5和Y具有如说明书中所定义的含义。